Royal Manchester Children’s Hospital / Manchester University
Department of Paediatric Allergy & Immunology
NHS Foundation Trust
Location: Manchester, United Kingdom
COE since 2025
Website: https://mft.nhs.uk/rmch/services/immunology/
Description: The Paediatric Allergy Service at Royal Manchester Children’s Hospital (RMCH) is one of the leading centres for the diagnosis, management, and research of children’s allergies in the United Kingdom. Situated within the country’s largest children’s hospital, the service benefits from advanced infrastructure, an experienced multidisciplinary team, and a commitment to clinical excellence and innovative research. It encourages and supports patient support groups, seeks patient feedback through engagement sessions and surveys to develop work plan and support standards and monitoring of the network.
Excellence in patient care: Our Center is a tertiary academic centre within one of the largest standalone children’s hospitals in Europe, servicing a population of 7 million. It is committed to delivering high-quality care through a patient-centred approach, to manage allergic and immunological conditions of all complexities. It promotes input from and education activities for patients, and local and national patient support groups. The team comprises a multidisciplinary group of paediatric allergy specialists supported by well-equipped diagnostic and therapeutic facilities with regular multidisciplinary clinics in conjunction with paediatric subspeciality colleagues in respiratory medicine, ENT, ophthalmology, rheumatology, gastroenterology and dermatology. It has access to the specialist tests within the adjoining tertiary, UKAS accredited laboratory for investigation of allergy and immunology disorders. We have also helped to develop and promote evaluation of rare genetic disorders within our Hospital’s Manchester Centre for Genomic Medicine (https://www.mangen.co.uk/).
Tertiary center leading allergy services within the region: Since 2007, our Center has provided clinical leadership for the North West Paediatric Allergy Network (www.allergynorthwest.nhs.uk), linking with the other tertiary service in the region, primary care and over 20 secondary care facilities throughout the North West of England and North Wales, as well as with adult services to provide seamless care of children and young people with allergic diseases. Our Network was the only Paediatric Center in the National Royal College of Physicians Future Hospital scheme, acknowledged for our innovative work in novel developments in paediatric allergy.
Cutting edge research: Our Center is at the cutting edge of novel diagnostic and therapeutic developments in allergy through our basic, translational and clinical trial involvement within the Centre and affiliated University of Manchester. Over the last 5 years, we have published over 50 peer reviewed original articles, including in high impact factor journals including New Engl J Med, Lancet, BMJ, Nature, Nature Genet, Cell. We are leaders in transitional research into allergic skin disorders in children, and also participate in clinical trials relating to food oral immunotherapy and eczema biologics.
Training excellence: Our Center provides training in evidence-based allergy and immunology and research for undergraduate and graduate clinical and science students, primarily through our close links with Lydia Becker Institute of Immunology & Inflammation at the University of Manchester. We also collaborate with other national academic institutes in the UK offering postgraduate courses in allergy. At the clinical postgraduate level, we are a recognised Center for national Grid training of paediatric allergy specialists, as well as paediatric trainees with a special interest in allergy (SPIN). We are also accredited to supervise international clinical allergy trainees as part of the Medical Training Initiative (paediatrics) (MTIp) scheme overseen by the Royal College of Paediatrics and Child Health (https://www.rcpch.ac.uk/resources/medical-training-initiative-paediatrics-available-posts).
NHS Foundation Trust
Location: Manchester, United Kingdom
COE since 2025
Website: https://mft.nhs.uk/rmch/services/immunology/
Description: The Paediatric Allergy Service at Royal Manchester Children’s Hospital (RMCH) is one of the leading centres for the diagnosis, management, and research of children’s allergies in the United Kingdom. Situated within the country’s largest children’s hospital, the service benefits from advanced infrastructure, an experienced multidisciplinary team, and a commitment to clinical excellence and innovative research. It encourages and supports patient support groups, seeks patient feedback through engagement sessions and surveys to develop work plan and support standards and monitoring of the network.
Excellence in patient care: Our Center is a tertiary academic centre within one of the largest standalone children’s hospitals in Europe, servicing a population of 7 million. It is committed to delivering high-quality care through a patient-centred approach, to manage allergic and immunological conditions of all complexities. It promotes input from and education activities for patients, and local and national patient support groups. The team comprises a multidisciplinary group of paediatric allergy specialists supported by well-equipped diagnostic and therapeutic facilities with regular multidisciplinary clinics in conjunction with paediatric subspeciality colleagues in respiratory medicine, ENT, ophthalmology, rheumatology, gastroenterology and dermatology. It has access to the specialist tests within the adjoining tertiary, UKAS accredited laboratory for investigation of allergy and immunology disorders. We have also helped to develop and promote evaluation of rare genetic disorders within our Hospital’s Manchester Centre for Genomic Medicine (https://www.mangen.co.uk/).
Tertiary center leading allergy services within the region: Since 2007, our Center has provided clinical leadership for the North West Paediatric Allergy Network (www.allergynorthwest.nhs.uk), linking with the other tertiary service in the region, primary care and over 20 secondary care facilities throughout the North West of England and North Wales, as well as with adult services to provide seamless care of children and young people with allergic diseases. Our Network was the only Paediatric Center in the National Royal College of Physicians Future Hospital scheme, acknowledged for our innovative work in novel developments in paediatric allergy.
Cutting edge research: Our Center is at the cutting edge of novel diagnostic and therapeutic developments in allergy through our basic, translational and clinical trial involvement within the Centre and affiliated University of Manchester. Over the last 5 years, we have published over 50 peer reviewed original articles, including in high impact factor journals including New Engl J Med, Lancet, BMJ, Nature, Nature Genet, Cell. We are leaders in transitional research into allergic skin disorders in children, and also participate in clinical trials relating to food oral immunotherapy and eczema biologics.
Training excellence: Our Center provides training in evidence-based allergy and immunology and research for undergraduate and graduate clinical and science students, primarily through our close links with Lydia Becker Institute of Immunology & Inflammation at the University of Manchester. We also collaborate with other national academic institutes in the UK offering postgraduate courses in allergy. At the clinical postgraduate level, we are a recognised Center for national Grid training of paediatric allergy specialists, as well as paediatric trainees with a special interest in allergy (SPIN). We are also accredited to supervise international clinical allergy trainees as part of the Medical Training Initiative (paediatrics) (MTIp) scheme overseen by the Royal College of Paediatrics and Child Health (https://www.rcpch.ac.uk/resources/medical-training-initiative-paediatrics-available-posts).